Circulating tumour cells for guiding antibody‒drug conjugate therapy: Role of artificial intelligence

Vahid Yaghoubi Naei, Mehran Dabiri, Lihua Chen, Jiajia Li, I‐Han Wang, Gungun Lin, Majid Ebrahimi Warkiani · 2026

Read Circulating tumour cells for guiding antibody‒drug conjugate therapy: Role of artificial intelligence by Vahid Yaghoubi Naei, Mehran Dabiri, Lihua Chen, Jiajia Li, I‐Han Wang, Gungun Lin, Majid Ebrahimi Warkiani (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13612861.txt.

Description

Yaghoubi Naei and six co-authors reviewed in twenty twenty-six whether tumor cells found in the blood could guide the use of antibody-drug conjugates, precision medicines that deliver poison straight to cancer cells. These drugs only work when the tumor wears the target the antibody seeks, and targets vary and shift over time.

A needle biopsy samples one spot once, while blood draws can be repeated and catch cells shed from many sites. The review weighs trial evidence for steering several cancer treatments by these circulating cells. It also examines how artificial intelligence sharpens the hunt for the rare cells and might one day recommend treatments. The authors are candid that direct proof for guiding this drug class is still thin. They propose practical frameworks for clinics to use the tests now, while calling for proper prospective trials.

Catalog record

CREATORVahid Yaghoubi Naei, Mehran Dabiri, Lihua Chen, Jiajia Li, I‐Han Wang, Gungun Lin, Majid Ebrahimi Warkiani
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE77 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13612861

Browse the full library · About the Tower of Babel